Axos beats on loan growth, guides to steady expansion
Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.
The earnings beat and its cause are the core new fact of the period.
Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.
Forward guidance tells readers where future earnings are headed, not just the last quarter.
Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.
Deal accretion and better credit quality are new supports for the stock.
Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.
It is the one real negative in the period and keeps the picture fair.